In the current study, we did not observe similar involvement of STAT3 in oral cancer (Fig. S8), suggesting that cell type differences between oral cancer (squamous cell carcinoma) and breast cancer (adenocarcinoma) may contribute to differences in the MRE11-preferential signaling pathways. Here, STAT3 is linked to breast carcinoma.